Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. Koen Raemdonck

Faculty of Pharmaceutical Sciences > Department of Pharmaceutics

Work address: Ottergemsesteenweg 460
9000 Gent
Email: Koen.Raemdonck@UGent.be
ORCID iD: 0000-0002-9807-4715

Show Sort by

Add to list
- Journal Article
- open access
Modulating intracellular pathways to improve non-viral delivery of RNA therapeutics

Thijs Van de Vyver, Stefaan De Smedt (UGent) and Koen Raemdonck (UGent)

(2022) Advanced Drug Delivery Reviews. 181.
Add to list
- Journal Article
- A1
- open access
Plasma membrane perforation by GSDME during apoptosis-driven secondary necrosis

Elke De Schutter (UGent) , Jana Ramon (UGent) , Benjamin Pfeuty, Caroline De Tender (UGent) , Stephan Stremersch (UGent) , Koen Raemdonck (UGent) , Ken Op de Beeck, Wim Declercq (UGent) , Franck Riquet (UGent) , Kevin Braeckmans (UGent) , et al.

(2022) CELLULAR AND MOLECULAR LIFE SCIENCES. 79(1).
Add to list
- Journal Article
- open access
Increasing Angiogenesis Factors in Hypoxic Diabetic Wound Conditions by siRNA Delivery: Additive Effect of LbL-Gold Nanocarriers and Desloratadine-Induced Lysosomal Escape

Elnaz Shaabani, Maryam Sharifiaghdam, Joris Lammens, Herlinde De Keersmaecker (UGent) , Chris Vervaet (UGent) , Thomas De Beer (UGent) , Elahe Motevaseli, Mohammad Hossein Ghahremani, Parvin Mansouri, Stefaan De Smedt (UGent) , et al.

(2021) International Journal of Molecular Sciences. 22(17).
Add to list
Non-viral transfection technologies for next-generation therapeutic T cell engineering

Laurens Raes (UGent) , Stefaan De Smedt (UGent) , Koen Raemdonck (UGent) and Kevin Braeckmans (UGent)

(2021) BIOTECHNOLOGY ADVANCES. 49.
Add to list
Pulmonary surfactant as a versatile biomaterial to fight COVID-19

Lore Herman (UGent) , Stefaan De Smedt (UGent) and Koen Raemdonck (UGent)

(2021) JOURNAL OF CONTROLLED RELEASE. 342. p.170-188
Add to list
Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics : getting the message across

An-Katrien Minnaert (UGent) , Helena Vanluchene (UGent) , Rein Verbeke (UGent) , Ine Lentacker (UGent) , Stefaan De Smedt (UGent) , Koen Raemdonck (UGent) , Niek Sanders (UGent) and Katrien Remaut (UGent)

(2021) ADVANCED DRUG DELIVERY REVIEWS. 176.
Add to list
- Journal Article
- A1
- open access
Cas9 RNP transfection by vapor nanobubble photoporation for ex vivo cell engineering

Laurens Raes, Melissa Pille (UGent) , Aranit Harizaj (UGent) , Glenn Goetgeluk (UGent) , Jelter Van Hoeck (UGent) , Stephan Stremersch (UGent) , Juan Fraire (UGent) , Toon Brans (UGent) , Olivier Gerrit de Jong, Roel Maas-Bakker, et al.

(2021) MOLECULAR THERAPY-NUCLEIC ACIDS. 25. p.696-707
Add to list
- Journal Article
- A1
- open access
Vapor nanobubble-mediated photoporation constitutes a versatile intracellular delivery technology

Jana Ramon (UGent) , Ranhua Xiong, Stefaan De Smedt (UGent) , Koen Raemdonck (UGent) and Kevin Braeckmans (UGent)

(2021) CURRENT OPINION IN COLLOID & INTERFACE SCIENCE. 54.
Add to list
Photothermal nanofibres enable safe engineering of therapeutic cells

Ranhua Xiong (UGent) , Dawei Hua (UGent) , Jelter Van Hoeck (UGent) , Dominika Berdecka (UGent) , Laurens Léger (UGent) , Stijn De Munter (UGent) , Juan Fraire (UGent) , Laurens Raes (UGent) , Aranit Harizaj (UGent) , Félix Sauvage (UGent) , et al.

(2021) NATURE NANOTECHNOLOGY. 16(11). p.1281-1291
Add to list
Non-invasive cell-tracking methods for adoptive T cell therapies

Jelter Van Hoeck (UGent) , Christian Vanhove (UGent) , Stefaan De Smedt (UGent) and Koen Raemdonck (UGent)

(2021) DRUG DISCOVERY TODAY.

1
2
3
4
…
8
9

Next →